Bright Minds Biosciences (DRUG) Net Income (2020 - 2026)
Bright Minds Biosciences' (DRUG) quarterly Net Income came in at -$7.6 million in Q1 2026, down 483.85% YoY from $2.0 million in Q1 2025, and down 40.59% on a QoQ basis from -$5.4 million in Q4 2025.
Powered by 
Analysis
Bright Minds Biosciences (DRUG) Net Income (2020 - 2026) Analysis & Trends
Bright Minds Biosciences (DRUG) has 7 years of Net Income data on file, last reported at -$7.6 million in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 601.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -782.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -644.37 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 237.01 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 164.49 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 81.49 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -13.27 Mn |
| 10 | Bright Minds Biosciences | 449.62 Mn | 227.08 Mn | - | -1.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.73 Mn |
| Mar 31, 2026 | -7.63 Mn |
| Dec 31, 2025 | -5.42 Mn |
| Sep 30, 2025 | 2.97 Mn |
| Jun 30, 2025 | 3.78 Mn |
| Mar 31, 2025 | 1.99 Mn |
| Dec 31, 2024 | 35,513.28 |
| Sep 30, 2024 | 566,973.56 |
| Jun 30, 2024 | -168,091.41 |
| Mar 31, 2024 | 2.93 Mn |
| Dec 31, 2023 | -1.24 Mn |
| Sep 30, 2023 | 1.14 Mn |
| Jun 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 1.72 Mn |
| Jun 30, 2022 | 2.09 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 3.85 Mn |
| Jun 30, 2021 | 2.87 Mn |
| Mar 31, 2021 | 1.25 Mn |